DUPILUMAB IMPROVED ASTHMA CONTROL ACROSS BASELINE IMMUNOGLOBULIN E LEVELS: LIBERTY ASTHMA QUEST STUDY

被引：1
|
作者：
Carr, W.
Corren, J.
Rice, M.
Deniz, Y.
Rowe, P.
Teper, A.
Khan, A.
Kamat, S.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2019年 / 123卷 / 05期
关键词：
D O I：
10.1016/j.anai.2019.08.289
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P223
引用
收藏
页码：S39 / S40
页数：3
相关论文
共 50 条
  • [21] Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study
    Maspero, Jorge F.
    Cardona, Guido
    Schonffeldt, Patricia
    Tolcachier, Alberto
    Gonzalez-Diaz, Sandra N.
    Yanez, Anahi
    Galvao, Clovis E.
    Msihid, Jerome
    Gall, Rebecca
    Siddiqui, Shahid
    Rowe, Paul J.
    Deniz, Yamo
    Jacob-Nara, Juby A.
    Djandji, Michel
    JOURNAL OF ASTHMA, 2023, 60 (05) : 981 - 990
  • [22] Dupilumab associated with lower reports of respiratory infections in moderate-to-severe asthma - safety analysis from the LIBERTY ASTHMA QUEST study
    Geng, B.
    Busse, W. W.
    Chen, Z.
    Ortiz, B.
    Rowe, P.
    Deniz, Y.
    ALLERGY, 2020, 75 : 17 - 17
  • [23] A Randomized, Controlled Phase 3 Study, LIBERTY ASTHMA QUEST, Evaluating the Efficacy and Safety of Dupilumab in Uncontrolled Moderate-to-Severe Asthma
    Castro, M.
    Corren, J.
    Pavord, I. D.
    Maspero, J. F.
    Wenzel, S. E.
    Rabe, K. F.
    Busse, W. W.
    Ford, L. B.
    Sher, L.
    FitzGerald, J.
    Katelaris, C.
    Tohda, Y.
    Zhang, B.
    Staudinger, H.
    Pirozzi, G.
    Amin, N.
    Ruddy, M.
    Akinlade, B.
    Khan, A.
    Chao, J.
    Martincova, R.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [24] Dupilumab Produces Rapid and Sustained Improvements in Asthma-Related Symptoms in Patients with Uncontrolled, Moderate-To-Severe Asthma from the LIBERTY ASTHMA QUEST Study
    Corren, J.
    Castro, M.
    Guillonneau, S.
    Chao, J.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [25] DUPILUMAB REDUCES SEVERE ASTHMA EXACERBATION RATES AND IMPROVES LUNG FUNCTION ACROSS A RANGE OF PRIOR EXACERBATIONS IN PATIENTS WITH ELEVATED TYPE 2 BIOMARKERS: THE LIBERTY ASTHMA QUEST STUDY
    Katelaris, Constance H.
    Douglass, Jo A.
    Ford, Linda B.
    Rice, Megan S.
    Moody, Jana
    Djandji, Michel
    Radwan, Amr
    Rowe, Paul
    Deniz, Yamo
    Amin, Nikhil
    Teper, Ariel
    INTERNAL MEDICINE JOURNAL, 2019, 49 : 34 - 35
  • [26] DUPILUMAB EFFICACY IN CHILDREN WITH UNCONTROLLED TYPE 2 ASTHMA ANALYZED BY BASELINE HIGH OR MEDIUM ICS DOSE: LIBERTY ASTHMA VOYAGE STUDY
    Maspero, J. F.
    Antila, M. A.
    Jean, N.
    Deschildre, A.
    Bacharier, L. B.
    Altincatal, A.
    Rimington, T.
    Laws, E.
    Akinlade, B.
    Radwan, A.
    Jacob-Nara, J. A.
    Deniz, Y.
    Rowe, P. J.
    Lederer, D. J.
    Hardin, M.
    THORAX, 2022, 77 : A77 - A78
  • [27] Effect of Dupilumab in Korean Patients With Uncontrolled Moderate-to-Severe Asthma: A LIBERTY ASTHMA QUEST Sub-analysis
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2022, 14 (02) : 182 - 195
  • [28] Dupilumab Improved Asthma Control and Health-Related Quality of Life in Patients with Oral-Corticosteroid-Dependent Severe Asthma in the Phase 3 LIBERTY ASTHMA VENTURE Study
    Ford, L. B.
    Rabe, K. F.
    Wolfe, R. N.
    Quirce, S.
    Rice, M. S.
    Rowe, P.
    Lu, Y.
    Kamat, S.
    Amin, N.
    Graham, N. M. H.
    Teper, A.
    Khan, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [29] Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Asthma by Immunoglobin E Levels at Baseline
    Carr, Warner
    Jackson, David J.
    Corren, Jonathan
    Bergmann, Karl-Christian
    Rice, Megan S.
    Deniz, Yamo
    Rowe, Paul
    Amin, Nikhil
    Teper, Ariel
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [30] DUPILUMAB REDUCED OCS USE IN ASTHMA PATIENTS ACROSS BASELINE CHARACTERISTICS
    Castro, M.
    Hanania, N.
    Daizadeh, N.
    Ortiz, B.
    Pandit-Abid, N.
    Deniz, Y.
    Rowe, P.
    RESPIROLOGY, 2021, 26 : 40 - 40
12345